"i think the quarterly report was fine, Well over $9m in cash"
You're 3mths behind - quarter just ended has $8.649m.
Might seem a petty correction but it represents an amount of cash burn which is 10x more than revenue for the quarter of $54k
"Facts are medical cannabis in this country and most western countries is inexcusably heavily government regulated because of big pharma !"
Dyor and you'll find the vast majority of revenue here is food.
They HAD a partner with a Medical Cannabis Licence - screwed that up.
Now they need a new licencee to continue in the MC sphere IF that's what the proposed acquisition is about.
It beggars belief at this point how come nobody at CGB itself is licenced by the ODC
Otherwise they might just be after a few health food shops.
- Forums
- ASX - By Stock
- CGB
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-101
-
-
- There are more pages in this discussion • 41 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CGB (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online